Goldman Sachs’s Columbia Research Enhanced Value ETF REVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-22,256
Closed -$637K 6924
2026
Q1
$637K Buy
+22,256
New +$648K ﹤0.01% 5432

Other funds holding REVS

Goldman Sachs's REVS Position: Q2 2026 in Review

Goldman Sachs sold out of Columbia Research Enhanced Value ETF (REVS) in Q2 2026, closing a stake of 22,256 shares — an estimated $637K sold.

Goldman Sachs first reported a position in REVS in Q1 2026 and held it in 1 quarter. The position peaked at $637K in Q1 2026. 38 funds tracked by Wall St. Rank hold REVS as of Q2 2026.

  • Goldman Sachs reported no remaining Columbia Research Enhanced Value ETF position as of Q2 2026 after selling out during the quarter.
  • Goldman Sachs sold 22,256 Columbia Research Enhanced Value ETF shares in Q2 2026, an estimated $637K.
  • Goldman Sachs first reported a position in Columbia Research Enhanced Value ETF in Q1 2026 and held it in 1 quarter.
  • Goldman Sachs's Columbia Research Enhanced Value ETF position peaked at $637K in Q1 2026.
  • 38 funds tracked by Wall St. Rank held Columbia Research Enhanced Value ETF as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.